Atlas Trials

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Clinical trial NCT01438073 · COMPLETED

Trial details

NCT number
NCT01438073
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypogonadotropic HypogonadismHealthy Postmenopausal WomenAgonadism
Start date
2011-09-01
Primary completion
2016-04-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.